Current treatment options for the management of patent ductus arteriosus

References

• Raval MV Laughon MM, Bose CL, Phillips JD. Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost? J Pediatr Surg. 2007;42(1):69–75; discussion 75.
   Web of Science ®Google Scholar
• Hsiao CC, Wung JT, T sao LY, Chang WC. Early or late surgical ligation of medical refractory patent ductus arteriosus in premature infants. J Formos Med Assoc. 2009;108(1):72–77.
   Web of Science ®Google Scholar
• Johnston PG, Gillam-Krakauer M, Fuller MP, Reese J. Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit. Clin Perinatol 2012;39(1):111–136.
   Web of Science ®Google Scholar
• Fanos V Marcialis MA, Bassareo PP, et al. Renal safety of non steroidal anti inflammatory drugs (NSAIDs) in the pharmacologic treatment of patent ductus arteriosus. J Matern Fetal Neonatal Med. 2011;24 Suppl 1:50–52.
   Google Scholar
• Romagnoli C, Bersani I, Rubortone SA, Lacerenza S, De Carolis MP Current evidence on the safety profile of NSAIDs for the treatment of PDA. J Matern Fetal Neonatal Med. 2011;24 Suppl 3:10–13.
   Google Scholar
• Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database SystRev. 2011;7:CD004213.
   Google Scholar
• Jones LJ, Craven PD, Attia J, Thakkinstian A, Wright I. Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2011 ;96(1): F45-F52.
   Web of Science ®Google Scholar
• Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2010;4:CD003481.
   Google Scholar
• Gouyon JB, Kibleur Y. Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants. Clin Ther. 2010;32(10):1740–1748.
   Web of Science ®Google Scholar
• Gork AS, Ehrenkranz RA, Bracken MB. Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. Cochrane Database Syst Rev. 2008;1:CD006071.
   Web of Science ®Google Scholar
• Porstmann W, Wiemy L, Warnke H, Gerstberger G, Romaniuk PA. Catheter closure of patent ductus arteriosus. 62 cases treated without thoracotomy. Radiol Clin North Am. 1971;9(2):203–218.
   Web of Science ®Google Scholar
• Rashkind WJ, Mullins CE, Hellenbrand WE, Tait MA. Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System. Circulation. 1987;75(3):583–592.
   Web of Science ®Google Scholar
• Cambier PA, Kirby WC, Wortham DC, Moore JW. Percutaneous closure of the small (less than 2.5 mm) patent ductus arteriosus using coil embolization. Am J Cardiol. 1992;69(8):815–816.
   Web of Science ®Google Scholar
• Ing FF, Bierman FZ. Percutaneous transcatheter coil occlusion of the patent ductus arteriosus aided by the nitinol snare: further observations. Cardiovasc Intervent Radiol 1995;18(4):222–226.
   Web of Science ®Google Scholar
• Ing FF, Mullins CE, Rose M, Shapir Y, Bierman FZ. Transcatheter closure of the patient ductus arteriosus in adults using the Gianturco coil. Clin Cardiol 1996;19(11):875–879.
   Web of Science ®Google Scholar
• Tomita H, Fuse S, Chiba S. Catecholamine-induced ductus arteriosus constriction in children. Am J Cardiol. 1996;77(15):1372–1375.
   Web of Science ®Google Scholar
• Tomita H, Fuse S, Akagi T, et al. Coil occlusion for patent ductus arteriosus in Japan. Jpn Circ J. 1997;61(12):997–1003.
   Google Scholar
• Grifka RG, Fenrich AL, Tapio JB. Transcatheter closure of patent ductus arteriosus and aorto-pulmonary vessels using non-ferromagnetic Inconel MReye embolization coils. Catheter Cardiovasc Interv. 2008;72(5):691–695.
   Web of Science ®Google Scholar
• Glatz AC, Petit CJ, Gillespie MJ. Novel use of a modified Amplatzer Vascular Plug to occlude a patent ductus arteriosus in two patients. Catheter Cardiovasc Interv. 2008;72(1):82–86.
   Web of Science ®Google Scholar
• Pass R. Amplatzer duct occluder device: a new technology for the closure of the moderate-to-large-sized patent ductus arteriosus. Expert Rev Med Devices. 2006;3(3):291–296.
   Web of Science ®Google Scholar
• Masura J, Tittel P, Gavora P, Podnar T. Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders. Am Heart J. 2006;151(3):755.e7–755.e10.
   Web of Science ®Google Scholar
• Lin CC, Hsieh KS, Huang TC, Weng KP. Closure of large patent ductus arteriosus in infants. Am J Cardiol. 2009;103(6):857–861.
   Web of Science ®Google Scholar
• Krichenko A, Benson LN, Burrows P, Moes CA, McLaughlin P, Freedom RM. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol. 1989;63(12):877–880.
   Web of Science ®Google Scholar
• Ing FF, Sommer RJ. The snare-assisted technique for transcatheter coil occlusion of moderate to large patent ductus arteriosus: immediate and intermediate results. J Am Coll Cardiol. 1999;33(6):1710–1718.
   Web of Science ®Google Scholar
• Ing FF, Recto MR, Saidi A, Denfield S, Mullins CE. A method providing bidirectional control of coil delivery in occlusions of patent ductus arteriosus with shallow ampulla and Pott’s shunts. Am J Cardiol. 1997;79(11):1561–1563.
   Web of Science ®Google Scholar
• Prieto LR, Latson LA, Dalvi B, Arbetman MM, Ebeid MR, Lamorgese TT. Transcatheter coil embolization of abnormal vascular connections using a new type of delivery catheter for enhanced control. Am J Cardiol. 1999;83(6):981–983, A10.
   Web of Science ®Google Scholar
• Gorenflo M, Ulmer HE, Brockmeier K. Successful closure of the arterial duct in the setting of rubella syndrome. Cardiol Young. 2002;12(2):200–202.
   Web of Science ®Google Scholar
• Ussia GP, Mule M, Caruso E, Aiello R, Tamburino C. Combined endothelin receptor antagonist and transcatheter interventional therapy of patent ductus arteriosus with severe pulmonary artery hypertension. Int J Cardiol. 2007;116(3):427–429.
   Web of Science ®Google Scholar
• Clyman RI. Surgical ligation of the patent ductus arteriosus: treatment or morbidity? J Pediatr. 2012;161(4):583–584.
   Web of Science ®Google Scholar
• Benjamin JR, Smith PB, Cotton CM, Jaggers J, Goldstein RF, Malcolm WF. Long-term morbidities associated with vocal cord paralysis after surgical closure of a patent ductus arteriosus in extremely low birth weight infants. J Perinatol. 2010;30(6):408–413.
   Web of Science ®Google Scholar
• Bedard MP, Shankaran S. Closure of PDA re risk of IVH. J Pediatr. 1983;102(6):1015–1016.
   Web of Science ®Google Scholar
• Clyman RI, Couto J, Murphy GM. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol. 2012;36(2):123–129.
   PubMed Web of Science ®Google Scholar
• Mirea L, Sankaran K, Seshia M, et al. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr. 2012;161(4):689–694. e1.
   PubMed Web of Science ®Google Scholar
• Madan JC, Kendrick D, Hagadom JI, Frantz ID 3rd; National Institute of Child Health and Human Development Neonatal Research Network. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics. 2009;123(2):674–681.
   PubMed Web of Science ®Google Scholar
• Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr. 2007;150(3): 229–234, 234.e1.
   Web of Science ®Google Scholar
• Vida VL, Lago P, Salvatori S, et al. Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants? Ann Thorac Surg. 2009;87(5):1509–1515; discussion 1515–1516.
   Web of Science ®Google Scholar
• Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2008;1:CD003951.
   Google Scholar
• Lemmers PM, Toet MC, van Bel F. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants. Pediatrics. 2008;121(1):142–147.
   PubMed Web of Science ®Google Scholar
• Vanderhaegen J, De Smet D, Meyns B, Van De Velde M, Van Huffel S, Naulaers G. Surgical closure of the patent ductus arteriosus and its effect on the cerebral tissue oxygenation. Acta Paediatr. 2008;97(12):1640–1644.
   Web of Science ®Google Scholar
• Jhaveri N, Moon-Grady A, Clyman RI. Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr. 2010;157(3):381–387, 387.e1.
   PubMed Web of Science ®Google Scholar
• Wickremasinghe AC, Rogers EE, Piecuch RE, et al. Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosus. J Pediatr. 2012;161(6):1065–1072.
   PubMed Web of Science ®Google Scholar
• Teixeira LS, Shivananda SP, Stephens D, Van Arsdell G, McNamara PJ. Postoperative cardiorespiratory instability following ligation of the preterm ductus arteriosus is related to early need for intervention. J Perinatol. 2008;28(12):803–810.
   Web of Science ®Google Scholar
• Smith ME, King JD, Elsherif A, Muntz HR, Park AH, Pouretas PC. Should all newborns who undergo patent ductus arteriosus ligation be examined for vocal fold mobility? Laryngoscope. 2009;119(8):1606–1609.
   Web of Science ®Google Scholar
• Clyman R, Cassady G, Kirklin JK, Collins M, Philips JB 3rd. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr. 2009;154(6):873–876.
   PubMed Web of Science ®Google Scholar